Palvella Therapeutics (PVLA) Return on Sales (QoQ) (2014 - 2024)

Palvella Therapeutics (PVLA) Return on Sales (QoQ) (2014 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Palvella Therapeutics 318.78 Mn 56.92 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 0.00
Jun 30, 2024 48.00
Mar 31, 2024 -42.00
Dec 31, 2023 -5.00
Sep 30, 2023 -1.00
Jun 30, 2023 8.00
Mar 31, 2023 82.00
Dec 31, 2022 -41.00
Sep 30, 2022 7.00
Jun 30, 2022 -55.00
Mar 31, 2022 1.00
Dec 31, 2021 3.00
Sep 30, 2021 18.00
Jun 30, 2021 -23.00
Mar 31, 2021 -4.00
Dec 31, 2020 9.00
Sep 30, 2020 -5.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00